(from draft UK HIV Testing Guidelines 2026)
| Category |
Condition |
| Neoplasm |
- Cervical cancer
- Non-Hodgkin lymphoma
- Kaposi’s sarcoma
|
| Bacterial infection |
- Mycobacterium tuberculosis, pulmonary or extrapulmonary
- Mycobacterium avium complex or Mycobacterium kansasii, disseminated or extrapulmonary
- Mycobacterium, other species or unidentified species, disseminated or extrapulmonary
- Pneumonia, recurrent (two or more episodes in 12 months)
- Salmonella septicaemia, recurrent
|
| Viral infection |
- Cytomegalovirus retinitis
- Cytomegalovirus, other (except liver, spleen, glands)
- Herpes simplex, ulcer(s) >1 month/bronchitis/pneumonitis
- Progressive multifocal leukoencephalopathy
|
| Parasitic infection |
- Cerebral toxoplasmosis
- Cryptosporidiosis diarrhoea, >1 month
- Isosporiasis, >1 month
- Atypical disseminated leishmaniasis
- Reactivation of American trypanosomiasis (meningoencephalitis or myocarditis)
|
| Fungal infection |
- Pneumocystis carinii pneumonia
- Candidiasis, oesophageal
- Candidiasis, bronchial/tracheal/pulmonary
- Cryptococcosis, extrapulmonary
- Histoplasmosis, disseminated/extrapulmonary
- Coccidioidomycosis, disseminated/extrapulmonary
- Talaromycosis (penicilliosis), disseminated
|
HIV transmission elimination
